Introduction
The peripheral stent market is on the rise globally, triggered by the rising incidence of peripheral artery disease (PAD), improvements in stent technology, and a transition towards minimally invasive interventions, which are mainly utilized to address blockages in arteries not located in the heart, have become critical instruments of vascular interventions, providing patients with enhanced results and shorter recovery times.
The Peripheral Stent Market is anticipated to grow at a CAGR of 6.1% during the forecast period of 2025-2031.
Get Sample Report: https://www.theinsightpartners.com/sample/TIPRE00040650
Growth Strategies
Technological Developments: The evolution of drug-eluting stents (DES) and bioresorbable stents has transformed the therapy options. DES deliver medication to inhibit restenosis, whereas bioresorbable stents slowly break down, diminishing long-term complications.
Minimally Invasive Procedures: The trend towards minimally invasive surgeries is growing as these treatments provide faster recovery and reduced risk over standard surgery. a fundamental part of these procedures, allowing effective therapies with lower patient downtime.
Regional Growth: Firms are increasing their presence in emerging regions, especially in Asia-Pacific, where the market is expected to grow by a CAGR of 7.9% during 2024-2030. This is on account of enhanced healthcare infrastructure and patient awareness.
Future Trends
Smart Technology Integration: The use of sensors and connectivity capabilities in stents enables real-time monitoring of vascular health, facilitating proactive management of patient conditions.
Personalized Medicine: Genomics and patient-specific information are driving customized stent designs and drug coatings, improving treatment efficacy and patient outcomes.
Regenerative Medicine: Bioresorbable scaffold and tissue-engineered solutions research is aiming to support natural vessel healing and minimize permanent implants.
Opportunities
Emerging Markets: The nations of Asia-Pacific and Latin America offer untapped markets with burgeoning healthcare investments and patient populations.
Product Innovation: Ongoing research on new materials and drug-delivery systems can result in stents with enhanced performance and fewer complications.
Collaborations and Partnerships: Strategic partnerships among medical device firms and healthcare providers can enable the release of sophisticated stent technology to a larger patient population.
Key Segments
By Product Type
Self-Expanding Stents
Balloon-Expandable Stents
Covered Stents
Drug-Eluting Stents
Bioresorbable Stents
By Indication
Peripheral Artery Disease
Coronary Artery Disease
Renal Artery Disease
Carotid Artery Disease
Other Vascular Diseases
By End-User
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Key Players with Recent Developments
Cordis (A Cardinal Health Company)
Cordis is further developing its portfolio of peripheral stents, with a continued emphasis on self-expanding and balloon-expandable technology. Their S.M.A.R.T.™ series, including the S.M.A.R.T.™ Flex and S.M.A.R.T.™ Control stents, are designed for lower extremity procedures. The PALMAZ™ Blue stent provides a balloon-expandable solution for a range of peripheral applications. Cordis places a high premium on clinical efficacy and patient outcomes in its products.
Cook Medical
Cook Medical has been awarded FDA Breakthrough Device designation for a new drug-eluting stent that will be used for below-the-knee (BTK) procedures. The stent is designed to treat chronic limb-threatening ischemia (CLTI), which is growing in prevalence. The designation is recognition of the potential of this device to provide more impactful treatment for patients with CLTI.
B. Braun Melsungen AG
B. Braun's affiliate, Aesculap, provides a variety, among them the Zilver® PTX® drug-eluting stent. The stent is intended for peripheral artery disease treatment, specifically in the superficial femoral artery. Aesculap remains devoted to innovation and patient results in its vascular intervention products
Conclusion
The peripheral stent industry is leading vascular intervention, fueled by technological advancements and a move towards patient-focused, minimally invasive therapy. With continuing innovation and increasing global accessibility, the future of peripheral stents is bright, with improved patient outcomes and alleviation of healthcare burdens. Healthcare players have to continue investing in research and development to take advantage of new opportunities and address changing patient needs across the globe.
